Genetic variation in staphylococcus aureus surface and immune evasion genes is lineage associated: Implications for vaccine design and host-pathogen interactions

BMC Microbiology

Volumn 10, Issue , 2010, Pages

  McCarthy, Alex J ^a   Lindsay, Jodi A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; PROTEIN CLFA; PROTEIN CLFB; PROTEIN CNA; PROTEIN COA; PROTEIN EAP; PROTEIN EBPS; PROTEIN ECB; PROTEIN EFB; PROTEIN EMP; PROTEIN ESAC; PROTEIN ESSC; PROTEIN FLIPR; PROTEIN FNBPB; PROTEIN ISAB; PROTEIN ISDA; PROTEIN ISDB; PROTEIN ISDH; PROTEIN SASB; PROTEIN SASC; PROTEIN SASD; PROTEIN SASF; PROTEIN SASK; PROTEIN SBI; PROTEIN SCIN B; PROTEIN SCIN C; PROTEIN SDRC; PROTEIN SDRE; PROTEIN SPA; PROTEIN SRAP; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; STAPHYLOCOCCUS VACCINE;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; DRUG DESIGN; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; NONHUMAN; NUCLEOTIDE SEQUENCE; STAPHYLOCOCCUS AUREUS; BACTERIAL GENOME; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PROTEIN MICROARRAY;

ANIMALIA; MAMMALIA; STAPHYLOCOCCUS AUREUS;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC VARIATION; GENOME, BACTERIAL; HOST-PATHOGEN INTERACTIONS; PROTEIN ARRAY ANALYSIS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS;

EID: 77954810303     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-10-173     Document Type: Article

References (118)

1. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. J Kluytmans A van Belkum H Verbrugh, Clin Microbiol Rev 1997 10 505 20 9227864
2. The clinical significance of methicillin-resistant Staphylococcus aureus. IM Gould, J Hosp Infect 2005 61 277 82 10.1016/j.jhin.2005.06.014 16216384
3. Methicillin-resistant staphylococci in companion animals. KE Baptiste K Williams NJ Willams A Wattret PD Clegg S Dawson JE Corkill T O'Neill CA Hart, Emerg Infect Dis 2005 11 1942 4 16485485
4. Prevalence of methicillin-resistant Staphylococcus aureus among staff and pets in a small animal referral hospital in the UK. A Loeffler AK Boag J Sung JA Lindsay L Guardabassi A Dalsgaard H Smith KB Stevens DH Lloyd, J Antimicrob Chemother 2005 56 692 7 10.1093/jac/dki312 16141276
5. Community-associated methicillin-resistant Staphylococcus aureus in horses and humans who work with horses. JS Weese J Rousseau JL Traub-Dargatz BM Willey AJ McGeer DE Low, J Am Vet Med Assoc 2005 226 580 3 10.2460/javma.2005. 226.580 15742700
6. Community-acquired MRSA and pig-farming. XW Huijsdens BJ van Dijke E Spalburg MG van Santen-Verheuvel ME Heck GN Pluister A Voss WJ Wannet AJ de Neeling, Ann Glin Microbiol Antimicrob 2006 5 26 10.1186/1476-0711-5-26 (Pubitemid 44823377)
7. Occurrence of methicillin-resistant Staphylococcus aureus in rats living on pig farms. AW van de Giessen MG van Santen-Verheuvel PD Hengeveld T Bosch EM Broens CB Reusken, Prev Vet Med 2009 91 270 3 10.1016/j.prevetmed.2009.05.016 19523703
8. Surface protein adhesins of Staphylococcus aureus. TJ Foster M Höök, Trends Microbiol 1998 6 484 8 10.1016/S0966-842X(98)01400-0 10036727
9. Surface adhesins of Staphylococcus aureus. SR Clarke SJ Foster, Adv Microb Physiol 2006 51 187 224 10.1016/S0065-2911(06)51004-5 17010697
10. A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1. C Prat J Bestebroer CJ de Haas JA van Strijp KP van Kessel, J Immunol 2006 177 8017 26 17114475
11. Staphylococcal complement evasion by various convertase blocking molecules. I Jongerius J Köhl MK Pandey M Ruyken KP van Kessel JA van Strijp SH Rooijakkers, J Exp Med 2007 204 2461 71 10.1084/jem.20070818 17893203
12. Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus. JD Burman E Leung KL Atkins MN O'Seaghdha L Lango P Bernadá S Bagby DI Svergun TJ Foster DE Isenman JM van den Elsen, J Biol Chem 2008 283 17579 93 10.1074/jbc.M800265200 18434316
13. Staphylococcus aureus host specificity: comparative genomics of human versus animal isolates by multi-strain microarray. JM Sung DH Lloyd JA Lindsay, Microbiology 2008 154 1949 59 10.1099/mic.0.2007/015289-0 18599823
14. Mapping the pathways to Staphylococcal pathogenesis by comparative secretomics. MJ Sibbald AK Ziebandt S Engelmann M Hecker A de Jong HJ Harmsen GC Raangs I Stokroos JP Arends JY Dubois JM van Dijl, Microbiol Mol Biol Rev 2006 3 755 88 10.1128/MMBR.00008-06 (Pubitemid 44484692)
15. How clonal is Staphylococcus aureus? EJ Feil JE Cooper H Grundmann DA Robinson MC Enright T Berendt SJ Peacock JM Smith M Murphy BG Spratt CE Moore NP Day, J Bacteriol 2003 185 3307 16 10.1128/JB.185.11.3307-3316.2003 12754228
16. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. DA Robinson MC Enright, Antimicrob Agents Chemother 2003 47 3926 34 10.1128/AAC.47.12.3926-3934.2003 14638503
17. Evolution of Staphylococcus aureus by large chromosomal replacements. DA Robinson MC Enright, J Bacteriol 2004 186 1060 4 10.1128/JB.186.4.1060-1064.2004 14762000
18. Global distribution of Panton-Valentine leukocidin - positive methicillin-resistant Staphylococcus aureus, 2006. A Tristan M Bes H Meugnier G Lina B Bozdogan P Courvalin ME Reverdy MC Enright F Vandenesch J Etienne, Emerg Infect Dis 2007 13 594 600 10.3201/eid1304.061316 17553275
19. Methicillin-resistant Staphylococcus aureus ST398 in humans and animals, Central Europe. W Witte B Strommenger C Stanek C Cuny, Emerg Infect Dis 2 255 8
20. Recent human-to poultry host jump, adaptation, and pandemic spread of Staphylococcus aureus. BV Lowder CM Guinane NL Ben Zakour LA Weinert A Conway-Morris RA Cartwright AJ Simpson A Rambaut U Nübel JR Fitzgerald, Proc Natl Acad Sci USA 2009 106 19545 50 10.1073/pnas.0909285106 19884497
21. Rapid determination of hospital-acquired meticillin-resistant Staphylococcus aureus lineages. JD Cockfield S Pathak JD Edgeworth JA Lindsay, J Med Microbiol 2007 56 614 9 10.1099/jmm.0.47074-0 17446283
22. Characterization of Baseline Methicillin-Resistant Staphylococcus aureus Isolates Recovered from Phase IV Clinical Trial for Linezolid. RE Mendes HS Sader LM Deshpande BA Diep HF Chambers RN Jones, J Clin Microbiol 2010 48 568 574 10.1128/JCM.01384-09 19940054
23. Characterization of novel LPXTG-containing proteins of Staphylococcus aureus identified from genome sequences. FM Roche R Massey SJ Peacock NP Day L Visai P Speziale A Lam M Pallen TJ Foster, Microbiology 2003 149 643 54 10.1099/mic.0.25996-0 12634333
24. Sequence diversity in the A domain of Staphylococcus aureus fibronectin binding protein A. A Loughman T Sweeney FM Keane G Pietrocola P Speziale TJ Foster, BMC Microbiol 2008 8 74 10.1186/1471-2180-8-74 18466610
25. Design, validation, and application of a seven-strain Staphylococcus aureus PCR product microarray for comparative genomics. AA Witney GL Marsden MT Holden RA Stabler SE Husain JK Vass PD Butcher J Hinds JA Lindsay, Appl Environ Microbiol 2005 71 7504 14 10.1128/AEM.71.11.7504-7514.2005 16269792
26. A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. NA Kuklin DJ Clark S Secore J Cook LD Cope T McNeely L Noble MJ Brown JK Zorman XM Wang G Pancari H Fan K Isett B Burgess J Bryan M Brownlow H George M Meinz ME Liddell R Kelly L Schultz D Montgomery J Onishi M Losada M Martin T Ebert CY Tan TL Schofield E Nagy A Meineke JG Joyce MB Kurtz MJ Caulfield,, et al. Infect Immun 2006 74 2215 23 10.1128/IAI.74.4. 2215-2223.2006 16552052
27. Vaccine assembly from surface proteins of Staphylococcus aureus. YK Stranger-Jones T Bae O Schneewind, Proc Natl Acad Sci USA 2006 103 16942 7 10.1073/pnas.0606863103 17075065
28. Vaccination with clumping factor A and fibronectin binding protein A to prevent Staphylococcus aureus infection of an aortic patch in mice. C Arrecubieta I Matsunaga T Asai Y Naka MC Deng FD Lowy, J Infect Dis 2008 198 571 5 10.1086/590210 18613794
29. Staphylococcus aureus-induced inflammation and bone destruction in experimental models of septic arthritis. E Josefsson A Tarkowski, J Periodontal Res 1999 34 387 92 10.1111/j.1600-0765.1999.tb02271.x 10685366
30. Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. AG Cheng HK Kim ML Burts T Krausz O Schneewind DM Missiakas, FASEB J 2009 23 3393 404 10.1096/fj.09-135467 19525403
31. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. AI Fattom J Sarwar A Ortiz R Naso, Infect Immun 1996 64 1659 65 8613375
32. Vaccine protection against Staphylococcus aureus pneumonia. J Bubeck Wardenburg O Schneewind, J Exp Med 2008 205 287 94 10.1084/jem.20072208 18268041
33. Prospects for a MRSA vaccine. JA Lindsay, Future Microbiol 2007 2 1 3 10.2217/17460913.2.1.1 17661669
34. Vaccination as infection control: a pilot study to determine the impact of Staphylococcus aureus vaccination on nasal carriage. CB Creech BG Johnson AR Alsentzer M Hohenboken KM Edwards TR Talbot, Vaccine 2009 28 256 60 10.1016/j.vaccine.2009.09.088 19799842
35. Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human Staphylococcal immune globulin, in low birth-weight infants. EV Capparelli BT Bloom TJ Kueser DG Oelberg EM Bifano RD White RL Schelonka SA Pearlman J Patti SV Hetherington, Antimicrob Agents Chemother 2005 49 4121 7 10.1128/AAC.49.10.4121-4127.2005 16189088
36. Vaccines against bovine mastitis in the New Zealand context: what is the best way forward? M Denis DN Wedlock SJ Lacy-Hulbert JE Hillerton BM Buddle, N Z Vet J 2009 57 132 40 19521461
37. Human factor in Staphylococcus aureus nasal carriage. J Nouwen H Boelens A van Belkum H Verbrugh, Infect Immun 2004 72 6685 8 10.1128/IAI.72.11.6685- 6688.2004 15501803
38. Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. SK Mazmanian G Liu H Ton-That O Schneewind, Science 1999 285 760 3 10.1126/science.285.5428.760 10427003
39. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin converting bacteriophages. WJ van Wamel SH Rooijakkers M Ruyken KP van Kessel JA van Strijp, J Bacteriol 2006 188 1310 5 10.1128/JB.188.4.1310- 1315.2006 16452413
40. Genetic diversity in CC398 methicillin-resistant Staphylococcus aureus isolates of different geographical origin. M Stegger JA Lindsay M Sørum KA Gould R Skov, Clin Microbiol Infect 2009 19681955
41. Genome sequence of a recently emerged highly-transmissible, multi-antibiotic and antiseptic resistant, variant of methicillin-resistant Staphylococcus aureus (MRSA) sequence-type 239 (TW). MT Holden JA Lindsay C Corton MA Quail JD Cockfield S Pathak R Batra J Parkhill SD Bentley JD Edgeworth, J Bacteriol 2010 192 888 92 10.1128/JB.01255-09 19948800
42. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. JD Thompson DG Higgins TJ Gibson, Nucleic Acids Res 1994 22 4673 80 10.1093/nar/22.22.4673 7984417
43. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. TA Hall, Nucleic Acids Symp Ser 1999 41 95 98
44. Locating proteins in the cell using TargetP, SignalP and related tools. O Emanuelsson S Brunak G von Heijne H Nielsen, Nat Protoc 2007 2 953 71 10.1038/nprot.2007.131 17446895
45. An outbreak in an intensive care unit of a strain of methicillin resistant Staphylococcus aureus sequence type 239 associated with an increased rate of vascular access device-related bacteremia. JD Edgeworth G Yadegarfar S Pathak R Batra JD Cockfield D Wyncoll R Beale JA Lindsay, Clin Infect Dis 2007 44 493 501 10.1086/511034 17243050
46. An outbreak of severe infections with community-acquired MRSA carrying the Panton-Valentine leukocidin following vaccination. CT Tang DT Nguyen TH Ngo TM Nguyen VT Le SD To J Lindsay TD Nguyen VC Bach QT Le TH Le DL Le J Campbell TK Nguyen VV Nguyen J Cockfield TG Le VN Phan HS Le TS Huynh VP Le M Counahan A BentsiEnchill R Brown J Simmerman TC Nguyen TH Tran J Farrar C Schultsz,, et al. PLoS ONE 2007 2 822 10.1371/journal.pone.0000822 17786194
47. Difference in virulence between Staphylococcus aureus isolates causing gangrenous mastitis versus subclinical mastitis in a dairy sheep flock. E Vautor J Cockfield C Le Marechal Y Le Loir M Chevalier DA Robinson R Thiery J Lindsay, Vet Res 2009 40 56 10.1051/vetres/2009039 19576164
48. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. MT Holden EJ Feil JA Lindsay SJ Peacock NP Day MC Enright TJ Foster CE Moore L Hurst R Atkin A Barron N Bason SD Bentley C Chillingworth T Chillingworth C Churcher L Clark C Corton A Cronin J Doggett L Dowd T Feltwell Z Hance B Harris H Hauser S Holroyd K Jagels KD James N Lennard A Line R Mayes,, et al. Proc Natl Acad Sci USA 2004 101 9786 91 10.1073/pnas.0402521101 15213324
49. Genome and virulence determinants of high virulence community-acquired MRSA. T Baba F Takeuchi M Kuroda H Yuzawa K Aoki A Oguchi Y Nagai N Iwama K Asano T Naimi H Kuroda L Cui K Yamamoto K Hiramatsu, Lancet 2002 359 1819 27 10.1016/S0140-6736(02)08713-5 12044378
50. Genomic analysis of an emerging multiresistant Staphylococcus aureus strain rapidly spreading in cystic fibrosis patients revealed the presence of an antibiotic inducible bacteriophage. JM Rolain P François D Hernandez F Bittar H Richet G Fournous Y Mattenberger E Bosdure N Stremler JC Dubus J Sarles M Reynaud-Gaubert S Boniface J Schrenzel D Raoult, Biol Direct 2009 4 1 10.1186/1745-6150-4-1 19144117
51. Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance. HM Neoh L Cui H Yuzawa F Takeuchi M Matsuo K Hiramatsu, Antimicrob Agents Chemother 2008 52 45 53 10.1128/AAC.00534-07 17954695
52. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. M Kuroda T Ohta I Uchiyama T Baba H Yuzawa I Kobayashi L Cui A Oguchi K Aoki Y Nagai J Lian T Ito M Kanamori H Matsumaru A Maruyama H Murakami A Hosoyama Y Mizutani-Ui NK Takahashi T Sawano R Inoue C Kaito K Sekimizu H Hirakawa S Kuhara S Goto J Yabuzaki M Kanehisa A Yamashita K Oshima K Furuya,, et al. Lancet 2001 357 1225 40 10.1016/S0140-6736(00)04403-2 11418146
53. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. MM Mwangi SW Wu Y Zhou K Sieradzki H de Lencastre P Richardson D Bruce E Rubin E Myers ED Siggia A Tomasz, Proc Natl Acad Sci USA 2007 104 9451 6 10.1073/pnas.0609839104 17517606
54. The Staphylococcus aureus NCTC 8325 Genome. AF Gillaspy V Worrell J Orvis BA Roe DW Dyer JJ Iandolo, Gram-positive pathogens ASM Press, Washington D.C, Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI, 2 2006 381 412
55. Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. T Baba T Bae O Schneewind F Takeuchi K Hiramatsu, J Bacteriol 2008 190 300 10 10.1128/JB.01000-07 17951380
56. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. BA Diep SR Gill RF Chang TH Phan JH Chen MG Davidson F Lin J Lin HA Carleton EF Mongodin GF Sensabaugh F Perdreau-Remington, Lancet 2006 367 731 9 10.1016/S0140-6736(06) 68231-7 16517273
57. Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. SK Highlander KG Hultén X Qin H Jiang S Yerrapragada EO Mason Jr Y Shang TM Williams RM Fortunov Y Liu O Igboeli J Petrosino M Tirumalai A Uzman GE Fox AM Cardenas DM Muzny L Hemphill Y Ding S Dugan PR Blyth CJ Buhay HH Dinh AC Hawes M Holder CL Kovar SL Lee W Liu LV Nazareth Q Wang J Zhou,, et al. BMC Microbiol 2007 7 99 10.1186/1471-2180-7-99 17986343
58. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. SR Gill DE Fouts GL Archer EF Mongodin RT Deboy J Ravel IT Paulsen JF Kolonay L Brinkac M Beanan RJ Dodson SC Daugherty R Madupu SV Angiuoli AS Durkin DH Haft J Vamathevan H Khouri T Utterback C Lee G Dimitrov L Jiang H Qin J Weidman K Tran K Kang IR Hance KE Nelson CM Fraser, J Bacteriol 2005 187 2426 38 10.1128/JB.187.7.2426-2438.2005 15774886
59. Molecular correlates of host specialization in Staphylococcus aureus. L Herron-Olson JR Fitzgerald JM Musser V Kapur, PLoS ONE 2007 2 1120 10.1371/journal.pone.0001120 17971880
60. The multifunctional Staphylococcus aureus autolysin aaa mediates adherence to immobilized fibrinogen and fibronectin. C Heilmann J Hartleib MS Hussain G Peters, Infect Immun 2005 73 4793 802 10.1128/IAI.73.8.4793-4802.2005 16040992
61. A structural model of the Staphylococcus aureus ClfA fibrinogen interaction opens new avenues for the design of anti-staphylococcal therapeutics. VK Ganesh JJ Rivera E Smeds YP Ko MG Bowden ER Wann S Gurusiddappa JR Fitzgerald M Höök, PLoS Pathog 2008 4 1000226 10.1371/journal. ppat.1000226 19043557
62. Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen. D McDevitt T Nanavaty K House-Pompeo E Bell N Turner L McIntire T Foster M Höök, Eur J Biochem 1997 247 416 24 10.1111/j.1432-1033.1997.00416.x 9249055
63. Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence. E Josefsson J Higgins TJ Foster A Tarkowski, PLoS One 2008 3 2206 10.1371/journal.pone.0002206 18493318
64. Identification of the Staphylococcus aureus MSCRAMM clumping factor B (ClfB) binding site in the alphaC-domain of human fibrinogen. EJ Walsh H Miajlovic OV Gorkun TJ Foster, Microbiology 2008 154 550 8 10.1099/mic.0.2007/ 010868-0 18227259
65. Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. D Ní Eidhin S Perkins P Francois P Vaudaux M Höök TJ Foster, Mol Microbiol 1998 30 245 57 10.1046/j.1365-2958.1998.01050.x 9791170
66. Molecular characterization and expression of a gene encoding a Staphylococcus aureus collagen adhesin. JM Patti H Jonsson B Guss LM Switalski K Wiberg M Lindberg M Höök, J Biol Chem 1992 267 4766 72 1311320
67. Structure of the collagen-binding domain from a Staphylococcus aureus adhesin. J Symersky JM Patti M Carson K House-Pompeo M Teale D Moore L Jin A Schneider LJ DeLucas M Höök SV Narayana, Nat Struct Biol 1997 4 833 8 10.1038/nsb1097-833 9334749
68. A 'Collagen Hug' model for Staphylococcus aureus CNA binding to collagen. Y Zong Y Xu X Liang DR Keene A Höök S Gurusiddappa M Höök SV Narayana, EMBO J 2005 24 4224 36 10.1038/sj.emboj.7600888 16362049
69. Structural comparison of ten serotypes of staphylocoagulases in Staphylococcus aureus. S Watanabe T Ito F Takeuchi M Endo E Okuno K Hiramatsu, J Bacteriol 2005 187 3698 707 10.1128/JB.187.11.3698-3707.2005 15901693
70. Genetic diversity of staphylocoagulase genes (coa): insight into the evolution of variable chromosomal virulence factors in Staphylococcus aureus. S Watanabe T Ito T Sasaki S Li I Uchiyama K Kishii K Kikuchi RL Skov K Hiramatsu, PLoS One 2009 4
71. eap Gene as novel target for specific identification of Staphylococcus aureus. M Hussain C von Eiff B Sinha I Joost M Herrmann G Peters K Becker, J Glin Microbiol 2008 46 470 6 10.1128/JCM.01425-07 (Pubitemid 351231288)
72. More than one tandem repeat domain of the extracellular adherence protein of Staphylococcus aureus is required for aggregation, adherence, and host cell invasion but not for leukocyte activation. M Hussain A Haggar G Peters GS Chhatwal M Herrmann JI Flock B Sinha, Infect Immun 2008 76 5615 23 10.1128/IAI.00480-08 18794290
73. The Staphyloccous aureus Eap protein activates expression of proinflammatory cytokines. TJ Scriba S Sierro EL Brown RE Phillips AK Sewell RC Massey, Infect Immun 2008 76 2164 8 10.1128/IAI.01699-07 18332207
74. Analysis of Ebh, a 1.1- megadalton cell wall-associated fibronectin-binding protein of Staphylococcus aureus. SR Clarke LG Harris RG Richards SJ Foster, Infect Immun 2002 70 6680 7 10.1128/IAI.70.12.6680-6687.2002 12438342
75. Staphylococcus aureus giant protein Ebh is involved in tolerance to transient hyperosmotic pressure. M Kuroda Y Tanaka R Aoki D Shu K Tsumoto T Ohta, Biochem Biophys Res Commun 2008 374 237 41 10.1016/j.bbrc.2008.07.037 18639517
76. Electron microscopy and computational studies of Ebh, a giant cell wall-associated protein from Staphylococcus aureus. S Sakamoto Y Tanaka I Tanaka T Takei J Yu M Kuroda M Yao T Ohta K Tsumoto, Biochem Biophys Res Commun 2008 376 261 6 10.1016/j.bbrc.2008.08.117 18771657
77. A helical string of alternately connected three- helix bundles for the cell wall-associated adhesion protein Ebh from Staphylococcus aureus. Y Tanaka S Sakamoto M Kuroda S Goda YG Gao K Tsumoto Y Hiragi M Yao N Watanabe T Ohta I Tanaka, Structure 2008 16 488 96 10.1016/j.str.2007.12.018 18334223
78. Characterization of the elastin binding domain in the cell-surface 25-kDa elastin-binding protein of staphylococcus aureus (EbpS). PW Park TJ Broekelmann BR Mecham RP Mecham, J Biol Chem 1999 274 2845 50 10.1074/jbc.274.5.2845 9915819
79. The elastin-binding protein of Staphylococcus aureus (EbpS) is expressed at the cell surface as an integral membrane protein and not as a cell wall-associated protein. R Downer F Roche PW Park RP Mecham TJ Foster, J Biol Chem 2002 277 243 50 10.1074/jbc.M107621200 11684686
80. The N-terminal domain of elastin-binding protein of Staphylococcus aureus changes its secondary structure in a membrane-mimetic environment. M Nakakido Y Tanaka K Tsumoto, J Biochem 2007 142 131 4 10.1093/jb/mvm131 17646183
81. Cloning and characterization of a gene for a 19 kDa fibrinogen-binding protein from Staphylococcus aureus. MK Bodén JI Flock, Mol Microbiol 1994 12 599 606 10.1111/j.1365-2958.1994.tb01046.x 7934883
82. Multiple binding sites in the interaction between an extracellular fibrinogen-binding protein from Staphylococcus aureus and fibrinogen. M Palma D Wade M Flock JI Flock, J Biol Chem 1998 273 13177 81 10.1074/jbc.273.21.13177 9582359
83. Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogen- binding protein (Efb). LY Lee X Liang M Höök EL Brown, J Biol Chem 2004 279 50710 6 10.1074/jbc.M408570200 15337748
84. Identification and characterization of a novel 38.5-kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins. M Hussain K Becker C von Eiff J Schrenzel G Peters M Herrmann, J Bacteriol 2001 183 6778 86 10.1128/JB.183.23. 6778-6786.2001 11698365
85. EsxA and EsxB are secreted by an ESAT-6-like system that is required for the pathogenesis of Staphylococcus aureus infections. ML Burts WA Williams K DeBord DM Missiakas, Proc Natl Acad Sci USA 2005 102 1169 74 10.1073/pnas.0405620102 15657139
86. EsaC substrate for the ESAT-6 secretion pathway and its role in persistent infections of Staphylococcus aureus. ML Burts AC DeDent DM Missiakas, Mol Microbiol 2008 69 736 46 10.1111/j.1365-2958.2008.06324.x 18554323
87. Identification of a fmtA-like gene that has similarity to other PBPs and beta lactamases in Staphylococcus aureus. H Komatsuzawa GH Choi T Fujiwara Y Huang K Ohta M Sugai H Suginaka, FEMS Microbiol Lett 2000 188 35 9 10867231
88. The fibronectin-binding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen. ER Wann S Gurusiddappa M Hook, J Biol Chem 2000 275 13863 71 10.1074/jbc.275.18.13863 10788510
89. The N-terminal A domain of fibronectin-binding proteins A and B promotes adhesion of Staphylococcus aureus to elastin. FM Roche R Downer F Keane P Speziale PW Park TJ Foster, J Biol Chem 2004 279 38433 40 10.1074/jbc.M402122200 15234962
90. Fibronectin binding proteins and fibrinogen-binding clumping factors play distinct roles in staphylococcal arthritis and systemic inflammation. N Palmqvist T Foster JR Fitzgerald E Josefsson A Tarkowski, J Infect Dis 2005 191 791 10.1086/427663 15688297
91. Fibrinogen and elastin bind to the same region within the A domain of fibronectin binding protein A, an MSCRAMM of Staphylococcus aureus. FM Keane A Loughman V Valtulina M Brennan P Speziale TJ Foster, Mol Microbiol 2007 63 711 23 10.1111/j.1365-2958.2006.05552.x 17302800
92. Crystal structures of fibronectin-binding sites from Staphylococcus aureus FnBPA in complex with fibronectin domains. RJ Bingham E Rudĩo-Pĩera NA Meenan U Schwarz-Linek JP Turkenburg M Höök EF Garman JR Potts, Proc Natl Acad Sci USA 2008 105 12254 8 10.1073/pnas.0803556105 18713862
93. Contribution of (sub)domains of Staphylococcus aureus fibronectin-binding protein to the proinflammatory and procoagulant response of human vascular endothelial cells. R Heying J van de Gevel YA Que L Piroth P Moreillon H Beekhuizen, Thromb Haemost 2009 101 495 504 19277411
94. Staphylococcus aureus immunodominant surface antigen B is a cell-surface associated nucleic acid binding protein. NM Mackey-Lawrence DE Potter N Cerca KK Jefferson, BMC Microbiol 2009 9 61 10.1186/1471-2180-9-61 19323837
95. IsdA of Staphylococcus aureus is a broad spectrum, iron-regulated adhesin. SR Clarke MD Wiltshire SJ Foster, Mol Microbiol 2004 51 1509 19 10.1111/j.1365-2958.2003.03938.x 14982642
96. Iron-regulated surface determinant protein A mediates adhesion of Staphylococcus aureus to human corneocyte envelope proteins. SR Clarke G Andre EJ Walsh YF Dufrne TJ Foster SJ Foster, Infect Immun 2009 77 2408 16 10.1128/IAI.01304-08 19307218
97. Passage of heme-iron across the envelope of Staphylococcus aureus. SK Mazmanian EP Skaar AH Gaspar M Humayun P Gornicki J Jelenska A Joachmiak DM Missiakas O Schneewind, Science 2003 299 906 9 10.1126/science.1081147 12574635
98. Immune evasion by Staphylococcus aureus conferred by iron-regulated surface determinant protein IsdH. L Visai N Yanagisawa E Josefsson A Tarkowski I Pezzali SH Rooijakkers TJ Foster P Speziale, Microbiology 2009 155 667 79 10.1099/mic.0.025684-0 19246738
99. Molecular characterization of a novel Staphylococcus aureus surface protein (SasC) involved in cell aggregation and biofilm accumulation. K Schroeder M Jularic SM Horsburgh N Hirschhausen C Neumann A Bertling A Schulte S Foster BE Kehrel G Peters C Heilmann, PLoS One 2009 4
100. Signal peptides direct surface proteins to two distinct envelope locations of Staphylococcus aureus. A DeDent T Bae DM Missiakas O Schneewind, EMBO J 2008 27 2656 68 10.1038/emboj.2008.185 18800056
101. The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation. RM Corrigan D Rigby P Handley TJ Foster, Microbiology 2007 153 2435 46 10.1099/mic.0.2007/006676-0 17660408
102. Staphylococcus aureus surface protein SasG contributes to intercellular autoaggregation of Staphylococcus aureus. M Kuroda R Ito Y Tanaka M Yao K Matoba S Saito I Tanaka T Ohta, Biochem Biophys Res Commun 2008 377 1102 6 10.1016/j.bbrc.2008.10.134 18983982
103. Staphylococcus aureus synthesizes adenosine to escape host immune responses. V Thammavongsa JW Kern DM Missiakas O Schneewind, J Exp Med 2009 206 2417 27 10.1084/jem.20090097 19808256
104. The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b. K Haupt M Reuter J van den Elsen J Burman S Hälbich J Richter C Skerka PF Zipfel, PLoS Pathog 2008 4 10.1371/journal.ppat.1000250 19112495
105. Structure-function analysis of the C3 binding region of Staphylococcus aureus immune subversion protein Sbi. A Upadhyay JD Burman EA Clark E Leung DE Isenman JM van den Elsen S Bagby, J Biol Chem 2008 283 22113 20 10.1074/jbc.M802636200 18550524
106. Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus. E Josefsson KW McCrea D Ní Eidhin D O'Connell J Cox M Höök TJ Foster, Microbiology 1998 144 3387 95 10.1099/00221287-144-12-3387 9884231
107. Surface proteins that promote adherence of Staphylococcus aureus to human desquamated nasal epithelial cells. RM Corrigan H Miajlovic TJ Foster, BMC Microbiol 2009 9 22 10.1186/1471-2180-9-22 19183486
108. The binding of calcium to the B-repeat segment of SdrD, a cell surface protein of Staphylococcus aureus. E Josefsson D O'Connell TJ Foster I Durussel JA Cox, J Biol Chem 1998 273 31145 52 10.1074/jbc.273.47.31145 9813018
109. Purification, characterization, and crystallization of the adhesive domain of SdrD from Staphylococcus aureus. L Zhang H Xiang J Gao J Hu S Miao L Wang X Deng S Li, Protein Expr Purif 2009 69 204 8 10.1016/j.pep.2009.09.007 19766722
110. Complete sequence of the staphylococcal gene encoding protein A. A gene evolved through multiple duplications. M Uhlén B Guss B Nilsson S Gatenbeck L Philipson M Lindberg, J Biol Chem 1984 259 1695 702 6319407
111. Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. J Hartleib N Köhler RB Dickinson GS Chhatwal JJ Sixma OM Hartford TJ Foster G Peters BE Kehrel M Herrmann, Blood 2000 96 2149 56 10979960
112. Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. MI Gámez A Lee B Reddy A Muir G Soong A Pitt A Cheung A Prince, Nat Med 2004 10 842 8 10.1038/nm1079 15247912
113. Role of SraP, a Serine-Rich Surface Protein of Staphylococcus aureus, in binding to human platelets. IR Siboo HF Chambers PM Sullam, Infect Immun 2005 73 2273 80 10.1128/IAI.73.4.2273-2280.2005 15784571
114. Role of SraP in adherence of Staphylococcus aureus to the bovine mammary epithelia. D Takamatsu E Hata M Osaki H Aso S Kobayashi T Sekizaki, J Vet Med Sci 2008 70 735 8 10.1292/jvms.70.735 18685250
115. A novel von Willebrand factor binding protein expressed by Staphylococcus aureus. J Bjerketorp M Nilsson A Ljungh JI Flock K Jacobsson L Frykberg, Microbiology 2002 148 2037 44 12101292
116. Staphylococcus aureus protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions. M O'Seaghdha CJ van Schooten SW Kerrigan J Emsley GJ Silverman D Cox PJ Lenting TJ Foster, FEBS J 2006 273 4831 41 10.1111/j.1742-4658.2006.05482.x 16999823
117. Von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombin. HK Kroh P Panizzi PE Bock, Proc Natl Acad Sci USA 2009 106 7786 91 10.1073/pnas.0811750106 19416890
118. Isolation and characterisation of a vitronectin-binding surface protein from Staphylococcus aureus. OD Liang JI Flock T Wadström, Biochim Biophys Acta 1995 1250 110 6 7612648